Cargando…

Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients

BACKGROUND: phosphate homeostasis is mediated through complex counter regulatory feed-back balance between parathyroid hormone, FGF-23 and 1,25(OH)2D. Both parathyroid hormone and FGF-23 regulate proximal tubular phosphate excretion through signaling on sodium- phosphate cotransporters II(a) and II(...

Descripción completa

Detalles Bibliográficos
Autores principales: Saki, Forough, Kassaee, Seyed Reza, Salehifar, Azita, Omrani, Gholam Hossein Ranjbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218502/
https://www.ncbi.nlm.nih.gov/pubmed/32398014
http://dx.doi.org/10.1186/s12882-020-01826-5
_version_ 1783532810315759616
author Saki, Forough
Kassaee, Seyed Reza
Salehifar, Azita
Omrani, Gholam Hossein Ranjbar
author_facet Saki, Forough
Kassaee, Seyed Reza
Salehifar, Azita
Omrani, Gholam Hossein Ranjbar
author_sort Saki, Forough
collection PubMed
description BACKGROUND: phosphate homeostasis is mediated through complex counter regulatory feed-back balance between parathyroid hormone, FGF-23 and 1,25(OH)2D. Both parathyroid hormone and FGF-23 regulate proximal tubular phosphate excretion through signaling on sodium- phosphate cotransporters II(a) and II(c). However, the interaction between these hormones on phosphate excretion is not clearly understood. We performed the present study to evaluate whether the existence of sufficient parathyroid hormone is necessary for full phosphaturic function of FGF-23 or not. METHODS: In this case-control study, 19 patients with hypoparathyroidism and their age- and gender-matched normal population were enrolled. Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software. RESULTS: The mean serum calcium and parathyroid hormone level was significantly lower in hypoparathyroid patients in comparison with the control group (P < 0.001 and P < 0.001, respectively). We found high serum level of phosphate and FGF-23 in hypoparathyroid patients compared to the control group (P < 0.001 and P < 0.001, respectively). However, there was no significant difference in Fractional excretion of phosphorous or 1,25OH2D level between the two groups. There was a positive correlation between serum FGF-23 and Fractional excretion of phosphorous just in the normal individuals (P < 0.001, r = 0.79). CONCLUSIONS: Although the FGF-23 is a main regulator of urinary phosphate excretion but the existence of sufficient parathyroid hormone is necessary for the full phosphaturic effect of FGF-23.
format Online
Article
Text
id pubmed-7218502
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72185022020-05-18 Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients Saki, Forough Kassaee, Seyed Reza Salehifar, Azita Omrani, Gholam Hossein Ranjbar BMC Nephrol Research Article BACKGROUND: phosphate homeostasis is mediated through complex counter regulatory feed-back balance between parathyroid hormone, FGF-23 and 1,25(OH)2D. Both parathyroid hormone and FGF-23 regulate proximal tubular phosphate excretion through signaling on sodium- phosphate cotransporters II(a) and II(c). However, the interaction between these hormones on phosphate excretion is not clearly understood. We performed the present study to evaluate whether the existence of sufficient parathyroid hormone is necessary for full phosphaturic function of FGF-23 or not. METHODS: In this case-control study, 19 patients with hypoparathyroidism and their age- and gender-matched normal population were enrolled. Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software. RESULTS: The mean serum calcium and parathyroid hormone level was significantly lower in hypoparathyroid patients in comparison with the control group (P < 0.001 and P < 0.001, respectively). We found high serum level of phosphate and FGF-23 in hypoparathyroid patients compared to the control group (P < 0.001 and P < 0.001, respectively). However, there was no significant difference in Fractional excretion of phosphorous or 1,25OH2D level between the two groups. There was a positive correlation between serum FGF-23 and Fractional excretion of phosphorous just in the normal individuals (P < 0.001, r = 0.79). CONCLUSIONS: Although the FGF-23 is a main regulator of urinary phosphate excretion but the existence of sufficient parathyroid hormone is necessary for the full phosphaturic effect of FGF-23. BioMed Central 2020-05-12 /pmc/articles/PMC7218502/ /pubmed/32398014 http://dx.doi.org/10.1186/s12882-020-01826-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Saki, Forough
Kassaee, Seyed Reza
Salehifar, Azita
Omrani, Gholam Hossein Ranjbar
Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title_full Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title_fullStr Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title_full_unstemmed Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title_short Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
title_sort interaction between serum fgf-23 and pth in renal phosphate excretion, a case-control study in hypoparathyroid patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218502/
https://www.ncbi.nlm.nih.gov/pubmed/32398014
http://dx.doi.org/10.1186/s12882-020-01826-5
work_keys_str_mv AT sakiforough interactionbetweenserumfgf23andpthinrenalphosphateexcretionacasecontrolstudyinhypoparathyroidpatients
AT kassaeeseyedreza interactionbetweenserumfgf23andpthinrenalphosphateexcretionacasecontrolstudyinhypoparathyroidpatients
AT salehifarazita interactionbetweenserumfgf23andpthinrenalphosphateexcretionacasecontrolstudyinhypoparathyroidpatients
AT omranigholamhosseinranjbar interactionbetweenserumfgf23andpthinrenalphosphateexcretionacasecontrolstudyinhypoparathyroidpatients